Efficacy and Safety of Oral Fosfomycin for Asymptomatic Bacteriuria in Kidney Transplant Recipients: Results from a Spanish Multicenter Cohort

Autor: Ruiz-Ruigomez M, Fernandez-Ruiz M, Silva J, Vidal E, Origuen J, Calvo-Cano A, Luna-Huerta E, Merino E, Hernandez D, Jironda-Gallegos C, Escudero-Sanchez R, Gioia F, Moreno A, Roca C, Cordero E, Janeiro D, Sanchez-Sobrino B, Montero M, Redondo D, Candel F, Perez-Flores I, Arminanzas C, Gonzalez-Rico C, Farinas M, Rodrigo E, Loeches B, Lopez-Oliva M, Montejo M, Lauzurica R, Horcajada J, Pascual J, Andres A, Aguado J, Lopez-Medrano F, REIPI Redinren GESITRA-IC SEIMC

Publikováno v: Antimicrobial agents and chemotherapy
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname

Current guidelines recommend against systematic screening for or treating asymptomatic bacteriuria (AB) among kidney transplant (KT) recipients, although the evidence regarding episodes occurring early after transplantation or in the presence of anat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::3dffca2d9a25c53d0b624b3da21a2b6b
https://fundanet.isabial.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=6990